FormularyDecisions

FormularyDecisions is a commercial healthcare technology platform used to facilitate information exchange between biopharma manufacturers and healthcare decision-makers, particularly payers and formulary reviewers. The platform supports product evaluation and market access workflows by allowing manufacturers to share clinical, economic, and evidence dossiers across the product lifecycle, including pre-approval and post-launch periods. It also serves as the home of the AMCP eDossier System and related payer-engagement tools used in reimbursement and formulary decision-making. Originally built by Dymaxium, the platform was acquired by Xcenda in 2019 and is now operated within Cencora's pharma solutions portfolio. The business is healthcare-related, but it is not a drug developer and does not maintain a therapeutic pipeline in the biotech sense.